Andere Sprachen Synairgen plc

Aktien

Markt geschlossen - London S.E. Andere Börsenplätze 17:35:08 07.05.2024			% 5 Tage	% 1. Jan.
5,91 ^GBX	-4,68 %		-4,68 %	-1,09 %

07.05.	AstraZeneca-Ziel angehoben; Antofagasta gesenkt	AN
2023	Synairgen ernennt Joseph Colliver von Phytome zum CFO	AN

AstraZeneca target raised; Antofagasta lowered	07.05.
Synairgen : IDWeek 2023 Poster Presentation	12.10.23
FTSE 100 Finishes Slightly Lower After Steady Session	11.10.23
Synairgen names Phytome's Joseph Colliver as CFO	11.10.23
Biotech Company Synairgen Names New CFO	11.10.23
Synairgen plc Announces Executive Changes	11.10.23
Synairgen plc Announces Board Changes	11.10.23
Synairgen promotes Marcin Mankowski to chief medical officer	03.10.23
Synairgen plc Announces Appointment of Dr. Marcin Mankowski as Chief Medical Officer	03.10.23
Synairgen narrows interim loss on reduced R&D spending	21.09.23
Synairgen looking beyond COVID in fight against respiratory illness	21.09.23
Synairgen : Interim Results	21.09.23
Earnings Flash (SNG.L) SYNAIRGEN Posts H1 Loss GBX-2.36	21.09.23
Synairgen plc Reports Earnings Results for the Half Year Ended June 30, 2023	21.09.23
Synairgen : ATS 2023 SPRINTER Poster Presentation	23.05.23
Synairgen : 2022 Annual Report	23.05.23
Synairgen CEO lays out plans for 2023 and beyond	28.04.23
Synairgen loss narrows; aims to develop SNG001	27.04.23
Earnings Flash (SNG.L) SYNAIRGEN Reports FY22 Loss GBX-8.76	27.04.23
Synairgen plc Reports Earnings Results for the Full Year Ended December 31, 2022	27.04.23

Keine Ergebnisse zu dieser Suche